Tumor Angiogenesis Correlates with Prognosis in Patients with Stage 3 Gastric Cancer.
- Author:
Kyung Suk CHUNG
1
;
Chang Gul HONG
;
Hyun Uk SHIN
;
Jung Weon SHIM
;
Hae Kyung AHN
Author Information
1. Department of General Surgery, College of Medicine, Hallym University, Korea.
- Publication Type:Original Article
- Keywords:
Tumor angiogenesis;
Gastric cancer;
Prognosis
- MeSH:
Breast;
Colon;
Follow-Up Studies;
Humans;
Lung;
Microvessels;
Mouth;
Multivariate Analysis;
Prognosis*;
Proportional Hazards Models;
Prostate;
Stomach Neoplasms*;
Survival Rate
- From:Journal of the Korean Cancer Association
1999;31(2):240-245
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Several studies suggest that tumor angiogenesis is a significant prognostic factor in carcinoma of the breast, lung, prostate, oral cavity, and colon. We assessed whether intensity of tumor angiogenesis, as measured by microvessel counts in histologic sections, correlates with prognosis in patients with stage III gastric cancer. MATERIALS AND METHODS: Paraffin-embedded sections from 49 patients (23 stage IIla, 26 stage IIIb) with primary gastric cancer that had been completely removed were analyzed for angiogenesis. Vessels were stained with anti-factor VIII polyclonal antibody, and areas with the most discrete microvessels were counted in a 200X field. RESULTS: Patients with stage IIIa gastric cancer had fewer microvessels than those with stage IIIb gastric cancer (32.8+-14.5 vs. 40.3+-16.1, P=0.106). The mean microvessel count from patients who were alive were significantly lower than that from patients who had died at the time of follow-up (24.8+-10.0 vs. 42.9+- 14.5, P=O.OOO). The 5-year survival rate of patients with count less than 33 microvessels was higher than that of patients with count more than 33 microvessels (59.9% vs. 11.6%, P= 0.000). On multivariate analysis by Cox proportional hazards model, the microvessel count was a significant prognostic factor of stage III gastric cancer. CONCLUSION: Tumor angiogenesis assessed by microvessel count may be a significant prognostic factor of stage III gastric cancer and may prove valuable in selecting patients with stage III gastric cancer for aggressive adjuvant therapy and closer postoperative follow-up.
